Rapid Micro Biosystems (RPID) Cash & Current Investments (2020 - 2026)

Rapid Micro Biosystems (RPID) has 7 years of Cash & Current Investments data on file, last reported at $9.4 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Current Investments fell 58.74% year-over-year to $9.4 million; the trailing twelve-month figure through Mar 2026 stood at $9.4 million (down 58.74% YoY), and the FY2025 full-year result was $18.4 million, down 63.8% from the prior year.
• Cash & Current Investments declined to $9.4 million in Q1 2026, from $18.4 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $162.2 million in Q1 2022 to a low of $9.4 million in Q1 2026.
• A 5-year average of $67.0 million and a median of $60.8 million in 2024 frame the typical range for Cash & Current Investments.
• Across the five-year window, Cash & Current Investments surged 430.72% in 2022 and sank 63.8% in 2025, its largest moves.
• Tracing RPID's Cash & Current Investments over 5 years: stood at $81.8 million in 2022, then declined by 17.02% to $67.9 million in 2023, then fell by 25.25% to $50.7 million in 2024, then slumped by 63.8% to $18.4 million in 2025, then slumped by 48.63% to $9.4 million in 2026.
• Business Quant data shows RPID's Cash & Current Investments at $9.4 million in Q1 2026, $18.4 million in Q4 2025, and $41.2 million in Q3 2025.